Nuclear power’s global revival

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Mounjaro and Zepbound are reshaping the treatment of obesity around the world. But even when these medicines are judged “cost-effective”, access often depends on who can afford to pay. In the second episode of our Business Daily se ...  Afficher plus

GLP-1 weight-loss drugs such as Ozempic, Wegovy, Zepbound and Mounjaro are reshaping the treatment of obesity — and transforming the global pharmaceutical market.Originally developed to treat type-2 diabetes, these injectable medicines — including semaglutide and tirzepatide — ar ...  Afficher plus

We could be on the verge of a nuclear power renaissance. Climate change is one reason: nuclear power remains the largest source of carbon-free energy in the United States. Also, demand for electricity is surging. BCG’s Ben Vannier imagines a future where the promise of less expen ...  Afficher plus

The calls for nuclear are growing louder. The Biden administration recently announced that it was putting $6 billion toward saving distressed nuclear power plants from closure, considering them carbon-free alternative to fossil fuels. Elon Musk doubled down, not only calling for ...  Afficher plus

At Climate Week NYC continues, the hottest topic is the question of how to meet growing demand for electricity while cutting emissions. In New York State, electricity use is expected to increase by 25% over the next 15 years. To meet that demand, the state plans to add tens of ...

Nuclear power is back at the centre of the global energy conversation again. Is a real renaissance in the industry under way? Or are we just in another moment of excitement before familiar challenges emerge and the hype cycle turns down again?

In the second of three spec ...